Shahzad Malik, Director, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), sold 535 shares at $11.00 ($6K) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market sale of $6k CNAT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VSAR | SELL | 2017-03-15 | $5.5M | — | Filing → |
| AGEN | SELL | 2015-04-30 | $7.9M | — | Filing → |
| VSAR | BUY | 2015-01-26 | $949K | — | Filing → |